Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands
Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 20...
Gespeichert in:
Veröffentlicht in: | European journal of cancer (1990) 2004-12, Vol.40 (18), p.2781-2787 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2787 |
---|---|
container_issue | 18 |
container_start_page | 2781 |
container_title | European journal of cancer (1990) |
container_volume | 40 |
creator | Boerma, E.G. van Imhoff, G.W. Appel, I.M. Veeger, N.J.G.M. Kluin, Ph.M. Kluin-Nelemans, J.C. |
description | Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (
n
=
203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (
n
=
27) and one for children (
n
=
80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of
MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81%
vs. 59%), whereas adults more often had nodal disease (89%
vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged. |
doi_str_mv | 10.1016/j.ejca.2004.09.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67136199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804904007452</els_id><sourcerecordid>67136199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</originalsourceid><addsrcrecordid>eNp9kM9u1DAQhy1URJfCC3CofCm3hHHsOLbUS1tBQargsnfLsSddb_Nna2cr9cY78IY8CU53pd44_TTSN78ZfYR8YlAyYPLLtsSts2UFIErQZY43ZMVUowtQdXVCVqBrXSgQ-pS8T2kLAI0S8I6csrpumJZsRR5vcfQYqR09tfdYROztjJ760HUYcXSYaBjp9T4-hHmm_fOw20yDpX9__6G4Cx6HMPXTfXC2f-lwfRhfBm9nS7s4DXS9QfoT5w3GPhPpA3nb2T7hx2OekfW3r-ub78Xdr9sfN1d3heOqmgvPlRLcMSm1ECgFAKtFy1rVdtpLho3i0KqG1dBWnLeVq5T22qIXIMFX_Ix8PtTu4vS4xzSbISSHff4Bp30ysmFcMq0zWB1AF6eUInZmF8Ng47NhYBbPZmsWz2bxbECbHHnp_Ni-bwf0rytHsRm4OAI2ZR1dtKML6ZWTXIJSy_XLA4dZxVPAaJILi3YfIrrZ-Cn8749_wlScQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67136199</pqid></control><display><type>article</type><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</creator><creatorcontrib>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</creatorcontrib><description>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (
n
=
203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (
n
=
27) and one for children (
n
=
80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of
MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81%
vs. 59%), whereas adults more often had nodal disease (89%
vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2004.09.004</identifier><identifier>PMID: 15571961</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Burkitt lymphoma ; Burkitt Lymphoma - epidemiology ; Chi-Square Distribution ; Child ; Clinical presentation ; Cohort Studies ; Epidemiology ; Extranodal ; Female ; Gender ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Netherlands - epidemiology ; Pharmacology. Drug treatments ; Registries ; Sex Distribution ; Tumors</subject><ispartof>European journal of cancer (1990), 2004-12, Vol.40 (18), p.2781-2787</ispartof><rights>2004 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</citedby><cites>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0959804904007452$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16360889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15571961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boerma, E.G.</creatorcontrib><creatorcontrib>van Imhoff, G.W.</creatorcontrib><creatorcontrib>Appel, I.M.</creatorcontrib><creatorcontrib>Veeger, N.J.G.M.</creatorcontrib><creatorcontrib>Kluin, Ph.M.</creatorcontrib><creatorcontrib>Kluin-Nelemans, J.C.</creatorcontrib><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (
n
=
203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (
n
=
27) and one for children (
n
=
80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of
MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81%
vs. 59%), whereas adults more often had nodal disease (89%
vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Burkitt lymphoma</subject><subject>Burkitt Lymphoma - epidemiology</subject><subject>Chi-Square Distribution</subject><subject>Child</subject><subject>Clinical presentation</subject><subject>Cohort Studies</subject><subject>Epidemiology</subject><subject>Extranodal</subject><subject>Female</subject><subject>Gender</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Netherlands - epidemiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Registries</subject><subject>Sex Distribution</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9u1DAQhy1URJfCC3CofCm3hHHsOLbUS1tBQargsnfLsSddb_Nna2cr9cY78IY8CU53pd44_TTSN78ZfYR8YlAyYPLLtsSts2UFIErQZY43ZMVUowtQdXVCVqBrXSgQ-pS8T2kLAI0S8I6csrpumJZsRR5vcfQYqR09tfdYROztjJ760HUYcXSYaBjp9T4-hHmm_fOw20yDpX9__6G4Cx6HMPXTfXC2f-lwfRhfBm9nS7s4DXS9QfoT5w3GPhPpA3nb2T7hx2OekfW3r-ub78Xdr9sfN1d3heOqmgvPlRLcMSm1ECgFAKtFy1rVdtpLho3i0KqG1dBWnLeVq5T22qIXIMFX_Ix8PtTu4vS4xzSbISSHff4Bp30ysmFcMq0zWB1AF6eUInZmF8Ng47NhYBbPZmsWz2bxbECbHHnp_Ni-bwf0rytHsRm4OAI2ZR1dtKML6ZWTXIJSy_XLA4dZxVPAaJILi3YfIrrZ-Cn8749_wlScQA</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Boerma, E.G.</creator><creator>van Imhoff, G.W.</creator><creator>Appel, I.M.</creator><creator>Veeger, N.J.G.M.</creator><creator>Kluin, Ph.M.</creator><creator>Kluin-Nelemans, J.C.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><author>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Burkitt lymphoma</topic><topic>Burkitt Lymphoma - epidemiology</topic><topic>Chi-Square Distribution</topic><topic>Child</topic><topic>Clinical presentation</topic><topic>Cohort Studies</topic><topic>Epidemiology</topic><topic>Extranodal</topic><topic>Female</topic><topic>Gender</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Netherlands - epidemiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Registries</topic><topic>Sex Distribution</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boerma, E.G.</creatorcontrib><creatorcontrib>van Imhoff, G.W.</creatorcontrib><creatorcontrib>Appel, I.M.</creatorcontrib><creatorcontrib>Veeger, N.J.G.M.</creatorcontrib><creatorcontrib>Kluin, Ph.M.</creatorcontrib><creatorcontrib>Kluin-Nelemans, J.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boerma, E.G.</au><au>van Imhoff, G.W.</au><au>Appel, I.M.</au><au>Veeger, N.J.G.M.</au><au>Kluin, Ph.M.</au><au>Kluin-Nelemans, J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>40</volume><issue>18</issue><spage>2781</spage><epage>2787</epage><pages>2781-2787</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 (
n
=
203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years (
n
=
27) and one for children (
n
=
80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of
MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81%
vs. 59%), whereas adults more often had nodal disease (89%
vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15571961</pmid><doi>10.1016/j.ejca.2004.09.004</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8049 |
ispartof | European journal of cancer (1990), 2004-12, Vol.40 (18), p.2781-2787 |
issn | 0959-8049 1879-0852 |
language | eng |
recordid | cdi_proquest_miscellaneous_67136199 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adolescent Adult Age Distribution Aged Aged, 80 and over Biological and medical sciences Burkitt lymphoma Burkitt Lymphoma - epidemiology Chi-Square Distribution Child Clinical presentation Cohort Studies Epidemiology Extranodal Female Gender Humans Male Medical sciences Middle Aged Multivariate Analysis Netherlands - epidemiology Pharmacology. Drug treatments Registries Sex Distribution Tumors |
title | Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gender%20and%20age-related%20differences%20in%20Burkitt%20lymphoma%20%E2%80%93%20epidemiological%20and%20clinical%20data%20from%20The%20Netherlands&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Boerma,%20E.G.&rft.date=2004-12-01&rft.volume=40&rft.issue=18&rft.spage=2781&rft.epage=2787&rft.pages=2781-2787&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2004.09.004&rft_dat=%3Cproquest_cross%3E67136199%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67136199&rft_id=info:pmid/15571961&rft_els_id=S0959804904007452&rfr_iscdi=true |